1. Recombinant adenovirus expressing hIFN-λ1 inhibits gastric adenocarcinoma cell line SGC-7901 proliferation
   XUEFENG BU et al, 2016, Oncology Letters CrossRef
2. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel
   W Feng et al, 2015, Cancer Gene Therapy CrossRef
3. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer
   Mona Schaalan et al, 2020, Microbial Pathogenesis CrossRef
4. New Insights into the Role of Autophagy in Tumor Immune Microenvironment
   Chia-Jung Li et al, 2017, International Journal of Molecular Sciences CrossRef
5. Immobilization rapidly selects for chemoresistant ovarian cancer cells with enhanced ability to enter dormancy
   Tiffany Lam et al, 2020, Biotechnology and Bioengineering CrossRef
6. Garcinol acts as an antineoplastic agent in human gastric cancer by inhibiting the PI3K/AKT signaling pathway
   Yuanyuan Zheng et al, 2020, Oncology Letters CrossRef
7. The expression profiling of circulating miR‐204, miR‐182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer
   Waleed A. Mohamed et al, 2019, Journal of Cellular Biochemistry CrossRef
8. A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognition
   Alexis R. Gibson et al, 2022, PLOS Pathogens CrossRef
9. The RNA m6A reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer
   Lichen Ge et al, 2024, Cell Death & Disease CrossRef
10. The role of IL-29 in immunity and cancer
    Noah E. Kelm et al, 2016, Critical Reviews in Oncology/Hematology CrossRef